Acoustic Cavitation Assisted Vascular Endothelial Growth Factor Transfection in Vitro.

Juan Tu,Dong Zhang,Chunbin Zhang,Qian Li,Feng Gao,Xiasheng Guo

DOI: https://doi.org/10.1121/1.3588178

2011-01-01

Abstract:Angiogenesis is a complex process that is mediated by growth factors such as vascular endothelial growth factor (VEGF). Researchers have reported that therapeutic ultrasound (US) is able to promote VEGF production in vitro, with the acoustic cavitation-induced sonopration. Here, with the presence of ultrasound contrast agents, the vascular endothelia cells mixed with VEGF165 were exposed to 1-MHz US pulses with varied acoustic parameters. The inertial cavitation (IC) activities accumulated during US exposure were quantified as IC dose (ICD) based on passive cavitation detection. The US sonoporation pores were examined with electron scan microscopy. The VEGF expression and the proliferation of the treated cells were evaluated based on ELISA and MTT assessments, respectively. The results show that (1) the ICD could be affected by US parameters (e.g., pressure, total treatment time, and PRF) and (2) the sonopration pore size, VEGF expression, and the cell proliferation were initially increased with the increasing ICD, then tended to saturate instead of achieving a maximum while the ICD kept going up. The results indicated that IC should play an important role in stimulating VEGF expression through sonopration, and ICD could be used as an effective tool to monitor and control the US-mediated drug delivery outcomes. [This work was funded by the National Basic Research Program of China (2011CB707900) and NSF of China (11074123 and 10974093).]